These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 32567070)

  • 1. Progress toward Alzheimer's disease treatment: Leveraging the Achilles' heel of Aβ oligomers?
    Fantini J; Chahinian H; Yahi N
    Protein Sci; 2020 Aug; 29(8):1748-1759. PubMed ID: 32567070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AmyP53 Prevents the Formation of Neurotoxic β-Amyloid Oligomers through an Unprecedent Mechanism of Interaction with Gangliosides: Insights for Alzheimer's Disease Therapy.
    Azzaz F; Chahinian H; Yahi N; Fantini J; Di Scala C
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene Therapy Strategy for Alzheimer's and Parkinson's Diseases Aimed at Preventing the Formation of Neurotoxic Oligomers in SH-SY5Y Cells.
    El-Battari A; Rodriguez L; Chahinian H; Delézay O; Fantini J; Yahi N; Di Scala C
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid β-protein oligomers promote the uptake of tau fibril seeds potentiating intracellular tau aggregation.
    Shin WS; Di J; Cao Q; Li B; Seidler PM; Murray KA; Bitan G; Jiang L
    Alzheimers Res Ther; 2019 Oct; 11(1):86. PubMed ID: 31627745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease.
    Behl T; Kaur I; Fratila O; Brata R; Bungau S
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are N- and C-terminally truncated Aβ species key pathological triggers in Alzheimer's disease?
    Dunys J; Valverde A; Checler F
    J Biol Chem; 2018 Oct; 293(40):15419-15428. PubMed ID: 30143530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Relevance of Amyloid β-Calmodulin Complexation in Neurons and Brain Degeneration in Alzheimer's Disease.
    Poejo J; Salazar J; Mata AM; Gutierrez-Merino C
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34067061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis.
    Viola KL; Klein WL
    Acta Neuropathol; 2015 Feb; 129(2):183-206. PubMed ID: 25604547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits.
    Izzo NJ; Staniszewski A; To L; Fa M; Teich AF; Saeed F; Wostein H; Walko T; Vaswani A; Wardius M; Syed Z; Ravenscroft J; Mozzoni K; Silky C; Rehak C; Yurko R; Finn P; Look G; Rishton G; Safferstein H; Miller M; Johanson C; Stopa E; Windisch M; Hutter-Paier B; Shamloo M; Arancio O; LeVine H; Catalano SM
    PLoS One; 2014; 9(11):e111898. PubMed ID: 25390368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AmyP53, a Therapeutic Peptide Candidate for the Treatment of Alzheimer's and Parkinson's Disease: Safety, Stability, Pharmacokinetics Parameters and Nose-to Brain Delivery.
    Di Scala C; Armstrong N; Chahinian H; Chabrière E; Fantini J; Yahi N
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broad neutralization of calcium-permeable amyloid pore channels with a chimeric Alzheimer/Parkinson peptide targeting brain gangliosides.
    Di Scala C; Yahi N; Flores A; Boutemeur S; Kourdougli N; Chahinian H; Fantini J
    Biochim Biophys Acta; 2016 Feb; 1862(2):213-22. PubMed ID: 26655601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synaptotoxic amyloid-β oligomers: a molecular basis for the cause, diagnosis, and treatment of Alzheimer's disease?
    Klein WL
    J Alzheimers Dis; 2013; 33 Suppl 1():S49-65. PubMed ID: 22785404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Pathogenesis Mechanism, Structure Properties, Potential Drugs and Therapeutic Nanoparticles against the Small Oligomers of Amyloid-β.
    Wang K; Na L; Duan M
    Curr Top Med Chem; 2021; 21(2):151-167. PubMed ID: 32938351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
    Tomiyama T
    Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage.
    Ferrera D; Mazzaro N; Canale C; Gasparini L
    Neurobiol Aging; 2014 Nov; 35(11):2444-2457. PubMed ID: 24973120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revisiting the Amyloid Cascade Hypothesis: From Anti-Aβ Therapeutics to Auspicious New Ways for Alzheimer's Disease.
    Uddin MS; Kabir MT; Rahman MS; Behl T; Jeandet P; Ashraf GM; Najda A; Bin-Jumah MN; El-Seedi HR; Abdel-Daim MM
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusible, highly bioactive oligomers represent a critical minority of soluble Aβ in Alzheimer's disease brain.
    Hong W; Wang Z; Liu W; O'Malley TT; Jin M; Willem M; Haass C; Frosch MP; Walsh DM
    Acta Neuropathol; 2018 Jul; 136(1):19-40. PubMed ID: 29687257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau immunotherapy modulates both pathological tau and upstream amyloid pathology in an Alzheimer's disease mouse model.
    Castillo-Carranza DL; Guerrero-Muñoz MJ; Sengupta U; Hernandez C; Barrett AD; Dineley K; Kayed R
    J Neurosci; 2015 Mar; 35(12):4857-68. PubMed ID: 25810517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Strategies Targeting Amyloid-β in Alzheimer's Disease.
    Pinheiro L; Faustino C
    Curr Alzheimer Res; 2019; 16(5):418-452. PubMed ID: 30907320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.